Nakanishi H, Yamada S, Kita J, Shinmura D, Hosokawa K, Sahara S, Misawa K. Auditory and Vestibular Characteristics of NLRP3 Inflammasome Related Autoinflammatory Disorders: Monogenic Hearing Loss Can Be Improved by Anti-interleukin-1 Therapy. Front Neurol 13; 865763, 2022. (IF:4.086)
Stephenson R, Mangasarian A, Ishiyama G, Hosokawa K, Hosokawa S, Ishiyama A, Lopez IA*: Immunohistochemical Location of Na+, K+-ATPase α1 subunit In the Human Inner Ear. Hear Res 400; 108113, 2021. (IF:3.672)
Endo S, Mizuta K*, Takahashi G, Arai M, Nakanishi H, Takizawa Y, Hosokawa K, Yamatodani T, Misawa K, Hosokawa S, Mineta H: Postoperative Course of Pars Flaccida Cholesteatoma Patients with Habitual Sniffing. Otol Neurotol 41(10) e1214-e1218, 2020. (IF:2.619)
Nakanishi H, Prakash P, Ito T, Kim HJ, Brewer CC, Harrow D, Roux I, Hosokawa S, Griffith AJ*: Genetic Hearing Loss Associated With Autoinflammation. Front Neurol 11; 141, 2020. (IF:4.086)
Umehara T1, Hosokawa S1*, Kita JY, Takahashi G, Okamura J, Nakanishi H, Hosokawa K, Kyou K, Hayashi Y, Mineta H: Risk Factors and Prognostic Factors of Hearing Impairment in Neonatal Intensive Care Uint-Treated Infants. Audiol Neurootol 24(2); 84-89, 2019. 1Both authors contributed equally. (IF:2.213)
Hosokawa S*, Hosokawa K, Takahashi G, Sugiyama KI, Nakanishi H, Takebayashi S, Mineta H: Hyperbaric Oxygen Therapy as Concurrent Treatment with Systemic Steroids for Idiopathic Sudden Sensorineural Hearing Loss: A Comparison of Three Different Steroid Treatments. Audiol Neurootol 23(3); 145-151, 2018. (IF:2.213)
Hosokawa S, Hosokawa K, Ishiyama G, Ishiyama A, Lopez IA*: Immunohistochemical localization of megalin and cubilin in the human inner ear. Brain Res 1701; 153-160, 2018. (IF:3.610)
Hosokawa K1, Hosokawa S1, Ishiyama G, Ishiyama A, Lopez IA*: Immunohistochemical localization of Nrf2 in the human cochlea. Brain Res 1700; 1-8, 2018. 1Both authors contributed equally. (IF:3.610)
Hosokawa K1, Hosokawa S1*, Takebayashi S, Mineta H: Trough-Shaped Audiograms Are Common in Patients with Acoustic Neuroma and Sudden Sensorineural Hearing Loss. Audiol Neurootol 23(1); 58-62, 2018. 1Both authors contributed equally. (IF:2.213)
Hosokawa S*, Sugiyama KI, Takahashi G, Hashimoto YI, Hosokawa K, Takebayashi S, Mineta H: Hyperbaric Oxygen Therapy as Adjuvant Treatment for Idiopathic Sudden Sensorineural Hearing Loss after Failure of Systemic Steroids. Audiol Neurootol 22(1); 9-14, 2017. (IF:2.213)
Hosokawa S*, Sugiyama K, Takahashi G, Takebayashi S, Mineta H: Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids. J Laryngol Otol 131(1); 77-82, 2017. (IF:2.187)
Yamatodani T*, Mizuta K, Endo S, Nakanishi H, Takahashi G, Misawa K, Hosokawa S, Mineta H: Clinical analysis of secondary acquired cholesteatoma. Arch Gen Intern Med 1(2); 10-14, 2017. (IF:0.000)
Lopez IA, Ishiyama G, Hosokawa S, Hosokawa K, Acuna D, Linthicum F, Ishiyama A*: Immunhistochemical techniques for the human inner ear. Histochem Cell Biol 146(4); 367-387, 2016. (IF:2.531)
Endo S, Mizuta K*, Takahashi G, Nakanishi H, Yamatodani T, Misawa K, Hosokawa S, Mineta H: The effect of ventilation tube insertion or trans-tympanic silicone plug insertion on a patulous Eustachian tube. Acta Otolaryngol 136(6); 551-555, 2016. (IF:1.698)
Vorasubin N, Hosokawa S, Hosokawa K, Ishiyama G, Ishiyama A, Lopez IA*: Neuroglobin immunoreactivity in the human cochlea. Brain Res 1630; 56-63, 2016. (IF:3.Res 1630; 56-63, 2016. (IF:3.610)
Nguyen KD, Mowlds D, Lopez IA, Hosokawa S, Ishiyama A, Ishiyama G*: Mu-opioid receptor (MOR) expression in the human spiral ganglia. Brain Res 1590; 10-19, 2014. (IF:3.610)
Ahmed S, Vorasubin N, Lopez IA*, Hosokawa S, Ishiyama G, Ishiyama A: The expression of glutamate aspartate transporter (GLAST) in different regions of the human cochlea and their relative distributions in various patient populations. Brain Res 1529; 134-142, 2013. (IF:3.610)
Takizawa Y*, Mizuta K, Hamada N, Yamatodani T, Nakanishi H, Hosokawa K, Takahashi G, Sugiyama K, Mineta H: Relationship between tympanic membrane retraction and habitual sniffing in patients with cholesteatoma. Acta Otolaryngol 133(10): 1030-1034, 2013. (IF:1.698)
Mizuta K*, Takizawa Y, Sugiyama K, Hosokawa S, Nakanishi H, Arai M, Adachi M, Mineta H: Ultrastructural localization of the G-protein Gs in the dark cells of rat vestibular organs. Practica Oto-rhino-laryngologica Suppl.136; 58-61, 2013. (IF:0.000)
Hosokawa S*, Mizuta K, Nakanishi H, Hashimoto Y, Arai M, Mineta H, Shindo S, Ikezono T: Ultrastructural localization of cochlin in the rat cochlear duct. Audiol Neurootol 15(4); 247-253, 2010. (IF:2.213)
総説・解説(欧文)
Hosokawa S, Hosokawa K, Ishiyama A, Acuna D, Linthicum FH Jr., Lopez IA*: Otosclerosis, Surprising Findings Revealed with Immunohistochemistry. Newsletter of the NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry 22(2); 5-7, 2015. (IF:0.000)
症例報告(欧文)
Hosokawa S*, Mizuta K: Conductive hearing loss and ear fullness due to a pulsatile mass in the middle ear. Ear Nose Throat 101(5):304-305, 2022. (IF:1.677)
Hosokawa S*, Mizuta K: Pulsatile tinnitus with a whitish mass in the middle ear. Eur Ann Otorhinolaryngol Head Neck Dis 138(5); 413-414, 2021. (IF:2.665)
Yamatodani T*, Misawa K, Endo S, Nakanishi H, Hosokawa S, Mineta H: An ameloblastoma in the middle ear. J Int Adv Otol 12 (1): 173-176, 2019. (IF:1.316)
Endo S*, Mizuta K, Nakanishi H, Yamatodani T, Hosokawa K, Misawa K, Hosokawa S, Mineta H: A case of improved hearing with cochlear implantation in Gaucher disease type 1. Auris Nasus Larynx 45 (3): 603-607, 2018. (IF:2.119)
Wester JL, Merna C, Peng KA, Lewis R, Sepahdari AR, Ishiyama G, Hosokawa K, Kumakawa K, Ishiyama A*: Facial nerve stimulation following cochlear implantation for X-linked stapes gusher syndrome leading to identification of a novel POU3F4 mutation. Int J Pediatr Otorhinolaryngol 91; 121-123, 2016. (IF: 1.626)
Suzuki Y, Naito T, Shibata K, Hosokawa S, Kawakami J: Associations of plasma aprepitant and its N-dealkylated metabolite with cachexia status and clinical responses in head and neck cancer patients. Cancer Chemother Pharmacol 91(6):481-490, 2023. (IF:3.288)
Hosokawa S*, Takahashi G, Okamura J, Imai A, Mochizuki D, Ishikawa R, Takizawa Y, Misawa K, Shinmura K, Mineta H: Relevance of Level IIb Neck Dissection in Patients with Papillary Thyroid Carcinomas. J Laryngol Otol 135(3); 269-272, 2021. (IF:2.187)
Shibata K, Naito T, Hirakawa S, Suzuki K, Hosokawa S, Mineta H, Kawakami J: Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients. Cancer Chemother Pharmacol 87(4) 555-565, 2021. (IF:3.288)
Hosokawa S*, Takahashi G, Sugiyama KI, Takebayashi S, Okamura J, Takizawa Y, Mineta H: Porfimer Sodium-mediated Photodynamic Therapy in Patients with Head and Neck Squamous Cell Carcinoma. Photodiagnosis Photodyn Ther 29; 101627, 2020. (IF:3.577)
Hosokawa S*, Takahashi G, Okamura J, Imai A, Mochizuki D, Ishikawa R, Takizawa Y, Yamatodani T, Misawa K, Mineta H: Management of elderly patients with head and neck carcinoma: analysis of outcomes for radical versus palliative treatment. Int J Clin Oncol 25 (3); 432-438, 2020. (IF:3.850)
Hosokawa S*, Mochizuki D, Takahashi G, Okamura J, Imai A, Ishikawa R, Takizawa Y, Yamatodani T, Misawa K, Mineta H: Relevance of Level IIb Neck Dissection in Patients with Head and Neck Squamous Cell Carcinomas. World J Surg 43(12); 3059-3064, 2019. (IF:3.282)
Hosokawa S*, Takebayashi S, Sasaki Y, Nakamura Y, Takahashi G, Shinmura K, Mineta H: Clinical analysis of false-negative fine needle aspiration cytology of head and neck cancers. Postgrad Med 131(2); 151-155, 2019. (IF4.379)
Kanno M, Narita N *, Fujimoto Y, Wakisaka N, Yoshizaki T, Kodaira T, Makita C, Sato Y, Yamazaki K, Wakaoka T, Shimode Y, Tsuji H, Kito R, Ishinaga H, Hosokawa S, Takakura H, Nishimura K, Matoba T, Fujieda S: Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015. Cancers (Basel) 11(8); 1180, 2019. (IF:6.575)
Shinmura K*, Kato H, Kawanishi Y, Yoshimura K, Tsuchiya K, Takahara Y, Hosokawa S, Kawase A, Funai K, Sugimura H: POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma. Cancers (Basel) 11(5); 722, 2019. (IF:6.575)
Mizukami T*, Ota Y, Okamura J, Yamatodani T, Hosokawa S, Fukamizu H: Reconstruction of temporal bone defects: Consideration for use of the submental island flap and temporalis muscle flap. B-ENT 15(1); 25-31, 2019. (IF:0.390)
Hosokawa S*, Takebayashi S, Sasaki Y, Mineta H: The Efficacy of Touch Smear Cytology in the Diagnosis of Salivary Gland Cancers. J Oral Maxillofac Surg 76(7); 1468.e1-1468.e4, 2018. (IF:2.136)
Hosokawa S*, Takebayashi S, Takahashi G, Okamura J, Mineta H: Photodynamic therapy in patients with head and neck squamous cell carcinoma. Lasers Surg Med 50 (5); 420-426, 2018. (IF:2.703)
Hosokawa S*, Takahashi G, Okamura J, Imai A, Mochizuki D, Takizawa Y, Yamatodani T, Misawa K, Mineta H: Risk and prognostic factors for multiple primary carcinomas in patients with head and neck cancer. Jpn J Clin Oncol 48(2); 124-129, 2018. (IF:2.925)
Shinmura K*, Kato H, Kawanishi Y, Kamo T, Inoue Y, Yoshimura Y, Sugiyama K, Misawa K, Hosokawa S, Mineta H, Sugimura H: BSND is a Novel Immunohistochemical Marker for Oncocytic Salivary Gland Tumors. Pathol Oncol Res 24 (2); 439-444, 2018. (IF:2.874)
Shibata K, Naito T*, Jun Okamura J, Hosokawa S, Mineta H, Kawakami J: Simple and rapid LC-MS/MS method for the absolute determination of cetuximab in human serum using an immobilized trypsin. J Pharm Biomed Anal 146; 266-272, 2017. (IF:3.571)
Misawa K*, Imai A, Mochizuki D, MisawaY, Endo S, Hosokawa S, Ishikawa R, Mima M, Kanazawa T, Mineta H: Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis. Oncotarget 8 (44): 76318-76328, 2017. (IF:0.000)
Hosokawa S*, Takahashi G, Baba S, Mineta H: Small Cell Neuroendocrine Carcinomas Arising in the Head and Neck Region. J Oral Maxillofac Surg 74(5); 1091-1095, 2016. (IF:2.136)
Hosokawa S*, Funai K, Sugiyama K, Takahashi G, Okamura J, Takizawa Y, Yamatodani T, Mineta H: Survival outcomes after surgical resection of pulmonary metastases of head and neck tumours. J Laryngol Otol 130(3); 291-295, 2016. (IF:2.187)
Hosokawa S*, Mizuta K, Takahashi G, Okamura J, Takizawa Y, Hosokawa K, Yamatodani T, Mineta H: Carcinoma of the external auditory canal: histological and treatment groups. B-ENT 10(4); 259-264, 2014. (IF:0.390)
Motohashi S, Mino Y, Hori K, Naito T, Hosokawa S, Furuse H, Ozono S, Mineta H, Kawakami J*: Interindividual variations in aprepitant plasma pharmacokinetics in cancer patients receiving cisplatin-based chemotherapy for the first time. Biol Pharm Bull 36 (4); 676-681, 2013. (IF:2.264)
Hosokawa S*, Mizuta K, Takahashi G, Okamura J, Takizawa Y, Hosokawa K, Yamatodani T, Mineta H: Surgical approach for treatment of carcinoma of the anterior wall of the external auditory canal. Otol Neurotol 33(3); 450-454, 2012. (IF:2.619)
Hosokawa S*, Okamura J, Takizawa Y, Takahashi G, Hosokawa K, Mineta H: Clinical study of mucosa-associated lymphoid tissue lymphoma of the head and neck. J Laryngol Otol 126(3); 271-275, 2012. (IF:2.187)
Kimura Y, Suzuki D, Tokunaga T, Takabayashi T, Yamada T, Wakisaka N, Yoshizaki T, Murata H, Miwa K, Shoujaku H, Watanabe Y, Yamada N, Ito Y, Yuta A, Takeuchi K, Hosokawa S, Mineta H, Hasegawa Y, Fujimoto Y, Nakashima T, Fujieda S*: Epidemiological analysis of nasopharyngeal carcinoma in the central region of Japan during the period from 1996 to 2005. Auris Nasus Larynx 38(2); 244-249, 2011. (IF:2.119)
レターもしくは論文形式のプロシーディングス(欧文)
Hosokawa S*, Mochizuki D, Takahashi G, Okamura J, Imai A, Ishikawa R, Takizawa Y, Yamatodani T, Misawa K, Mineta H: Authors’ Reply: Relevance of Level IIb Neck Dissection in Patients with Head and Neck Squamous Cell Carcinomas. World J Surg 44(5); 1693, 2020. (IF:3.282)
Meguro S, Kusama Y, Matsushima S, Yagi H, Kawasaki H, Kosugi I, Tsuchida T, Baba S, Enomoto Y, Hosokawa S, Iwashita T*. Nasal glomus tumor: A rare nasal tumor with diffuse and strongly positive synaptophysin expression. Pathol Int 69 (11); 672-674, 2019. (IF:2.121)
Kasuya A*, Shinkai S, Sakamoto S, Hosokawa S, Imai A, Sakai S, Oki T, Tokura Y: Intractable disseminated maculopapular eruption in a patient with GM-CSF-producing anaplastic thyroid carcinoma. J Dermatol 46 (11); e432-433, 2019. (IF:3.468)
症例報告(欧文)
Matsushita A, Hosokawa S*, Mochizuki D, Okamura J, Funai K, Mineta H: Emergent thyroidectomy with sternotomy due to acute respiratory failure with severe thyroid storm. Ann R Coll Surg Engl 100 (8): e223-e225, 2018. (IF:1.951)
Hosokawa S*, Takebayashi S, Mineta H: The impact of iatrogenic glottic atresia due to photodynamic therapy for laryngeal cancer: A report of two cases. Photodiagnosis Photodyn Ther 21:153-155, 2018. (IF:3.577)
Hosokawa S*, Okamura J, Takizawa Y, Mineta H: Long-term survival of a patient with primary small cell neuroendocrine carcinoma of the maxillary sinus: a case report. J Oral Maxillofac Surg 71 (8): e248-e252, 2013. (IF:2.136)
Hosokawa S*, Okamura J, Sakai N, Mineta H: Primary spindle cell carcinoma of the frontal sinus. J Oral Maxillofac Surg 70 (11): e674-e678, 2012. (IF:2.136)
Hosokawa S*, Takebayashi S, Mineta H, Suzuki K, Baba S: Undifferentiated sarcoma of the maxillary sinus: Report of a rare case in an adult. Auris Nasus Larynx 36 (1): 92-95, 2009. (IF:2.119)
Hosokawa S*, Mizuta K, Iwasaki S, Araki S, Takebayashi S, Mineta H: A rare case of metastasis to the temporal bone from prostate adenocarcinoma . The Internet Journal of Head and Neck Surgery. Volume 1 Number 2, 2007. (IF:0.000)
Hosokawa S*, Mineta H: Nasopharyngeal mass mimicking carcinoma caused by sexually transmitted infection.
Postgrad Med J 96 (1131): 55, 2020. (IF:4.973)
Hosokawa S*, Kusama Y, Ono T, Mineta H: Toxoplasma lymphadenitis diagnosed by fine-needle aspiration
cytology: a rare finding. J Laryngol Otol 128 (6): 561-564, 2014. (IF:2.187)
Mochizuki T*, Kamio Y, Hosokawa S, Kimura T, Yoshino A: Brain infarction after dissection of the
intrathoracic arteries secondary to acute epiglottitis. Am J Emerg Med 31(2): 463.e3-e5, 2013. (IF:4.093)